Lisa Belfiore
Lisa Belfiore
Unknown affiliation
Verified email at uowmail.edu.au
Title
Cited by
Cited by
Year
Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
L Belfiore, DN Saunders, M Ranson, KJ Thurecht, G Storm, KL Vine
Journal of controlled release 277, 1-13, 2018
772018
Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin
UA Bommer, KL Vine, P Puri, M Engel, L Belfiore, K Fildes, M Batterham, ...
Cell Communication and Signaling 15 (1), 1-15, 2017
172017
The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon‐γ in a humanized mouse model of graft‐versus‐host disease
NJ Geraghty, L Belfiore, D Ly, SR Adhikary, SJ Fuller, W Varikatt, ...
Clinical & Experimental Immunology 190 (1), 79-95, 2017
162017
N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines
KL Vine, L Belfiore, L Jones, JM Locke, S Wade, E Minaei, M Ranson
Heliyon 2 (1), e00060, 2016
142016
Quantification of ligand density and stoichiometry on the surface of liposomes using single-molecule fluorescence imaging
L Belfiore, LM Spenkelink, M Ranson, AM van Oijen, KL Vine
Journal of Controlled Release 278, 80-86, 2018
112018
Increased splenic human CD4+: CD8+ T cell ratios, serum human interferon-γ and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in …
NJ Geraghty, L Belfiore, SR Adhikary, SI Alexander, R Sluyter, D Watson
Transplant Immunology 54, 38-46, 2019
62019
N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer
L Belfiore, DN Saunders, M Ranson, KL Vine
Pharmaceutics 12 (7), 641, 2020
2020
Increased splenic human CD4 (+): CD8 (+) T cell ratios
NJ Geraghty, L Belfiore, SR Adhikary, SI Alexander, R Sluyter, D Watson
2019
Development of Ligand-Directed Drug-Loaded Liposomes to Target Heterogeneous Tumour Cell Populations in Metastatic Breast Cancer
L Belfiore
2019
Pro-inflammatory role of the ATP/P2X7 signalling axis in graft-versus-host disease in humanised mice
NJ Geraghty, SR Adhikary, P Cuthbertson, D Ly, T Guy, L Belfiore, ...
PURINERGIC SIGNALLING 14, S57-S58, 2018
2018
P2X7 polymorphisms and the role of P2X7 in graft-versus-host disease
S Adhikary, N Geraghty, L Belfiore, S Alexander, R Sluyter, D Watson
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 725-725, 2016
2016
P2X7 BLOCKADE REDUCES INTERFERON GAMMA IN A HUMANISED MOUSE MODEL OF GRAFT-VERSUS-HOST DISEASE.
N Geraghty, L Belfiore, P Mullany, SR Adhikary, S Alexander, R Sluyter, ...
TRANSPLANTATION 99 (11), S5-S5, 2015
2015
THE HUMAN IMMUNE RESPONSE IN HUMANISED MICE WITH AND WITHOUT GRAFT-VERSUS-HOST DISEASE (GVHD)
W Debbie, G Nicholas, B Lisa, M Phillip, A Stephen, S Ronald
Immunology and Cell Biology 93 (9), 2015
2015
P2X7 RECEPTOR BLOCKADE REDUCES THE CONCENTRATION OF CIRCULATING INTERFERON GAMMA IN A HUMANISED MOUSE MODEL OF GRAFT-VERSUS-HOST DISEASE
G Nicholas, B Lisa, M Phillip, A Stephen, S Ronald, W Debbie
Immunology and Cell Biology 93 (9), 2015
2015
TCTP is induced early in colorectal cancer, it is translationally regulated via the Akt/mTORC1 pathway, and it contributes to the resistance of HCT116 colon cancer cells to 5 …
UA Bommer, KL Vine, V Iadevaia, L Belfiore, M Engel, P Puri, A Lochhead, ...
Febs Journal 282, 95-95, 2015
2015
Investigating the effects of purinergic receptor (P2X7R) blockade on the development of graft-versus-host-disease (gvhd) in humanised mice
D Watson, L Belfiore, SI Alexander, R Sluyter
2014
The system can't perform the operation now. Try again later.
Articles 1–16